A Pilot Study to Assess the Impact of Exposure to Popular Media Content on Patients Living With Obesity
1 other identifier
interventional
20
1 country
1
Brief Summary
This study will explore the impact of exposure to popular media content on patients living with obesity. Findings from this study will provide new insights that will extend current understanding of exposure to media portrayal. This is a proof of principle pilot study that will evaluate the feasibility of recruitment, randomisation, assessment procedures and implementation of the intervention with the aim to facilitate the planning and the conduct of a full-scale randomised controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2021
CompletedFirst Submitted
Initial submission to the registry
July 19, 2021
CompletedFirst Posted
Study publicly available on registry
August 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 17, 2022
May 1, 2022
1.5 years
July 19, 2021
May 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cortisol levels
To characterise the effect of a modified media content upon cortisol secretion in people living with obesity.
up to 4 hours
Secondary Outcomes (7)
heart rate
up to 4 hours
systolic and diastolic blood pressure
up to 4 hours
blood glucose
up to 4 hours
salivary hormones
up to 4 hours
inflammatory cytokines
up to 4 hours
- +2 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALmodified media content experience
Control
ACTIVE COMPARATORmedia content experience
Interventions
Eligibility Criteria
You may qualify if:
- Female adults aged 18-65 years.
- Body Mass Index equal or greater than 30 kg/m2.
- Weight stable at time of recruitment, defined as less than 5% variation in body weight over the preceding 3 months.
- Proficient in written and spoken English.
- Able to comply with study protocol.
- Willing and able to provide written informed consent.
You may not qualify if:
- Type 1 and type 2 diabetes (in view of altered circulated gut hormone profiles and gustatory function).
- Smoking (in view of the fact that smoking affects salivary cortisol).
- Diagnosed with uncontrolled severe depression.
- Diagnosed with uncontrolled psychiatric disorder.
- Previous bariatric surgery.
- Acute illness or chronic conditions that may impact HPA including Cushing syndrome.
- Known or suspected history of HIV, Hepatitis B or C or other blood-borne diseases (in view of safety regulations regarding exposure to blood products).
- Currently using glucocorticoids.
- Pregnancy or lactation.
- Elevated self-perceived stress as assessed by the Perceived Stress Scale.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College London Hospital
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not know what group they are allocated to until the intervention is delivered.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2021
First Posted
August 12, 2021
Study Start
July 9, 2021
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
May 17, 2022
Record last verified: 2022-05